Are Options Traders Bullish on BGNE?
Let daily Option Order Flow show you where stock investors are Bullish and Bearish!!! Receive a FREE daily email of the Market Chameleon Order Flow Sentiment Newsletter.
Market Chameleon

About BGNE

BeiGene is a global, clinical-stage, research-based biotechnology company focused on molecularly targeted and immuno-oncology cancer therapeutics. With a team of over 300 scientists, clinicians and staff in mainland China, the United States, Australia and Taiwan, BeiGene is advancing a pipeline consisting of novel oral small molecules and monoclonal antibodies for cancer. BeiGene is working to create combination solutions aimed to have both a meaningful and lasting impact on cancer patients.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

BGNE is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
ADRA Invesco BLDRS Asia 50 ADR Index Fund 18.1 M 1.81E+07 50 50 0.4% 0.00402 72 K 72376
ADRE Invesco BLDRS Emerging Markets 50 ADR Index Fund 130.2 M 1.302E+08 50 50 0.47% 0.00468 605 K 605483
BIB ProShares Ultra Nasdaq Biotechnology 274.1 M 2.74063E+08 235 235 0.26% 0.00262667 1.6 M 1575750
IBB iShares Nasdaq Biotechnology Index Fund 8.2 B 8.22605E+09 224 224 0.72% 0.0072 58.6 M 5.85999E+07
ONEQ Fidelity Nasdaq Composite Index Tracking Stock 1.7 B 1.7E+09 1,015 1015 0.04% 0.000393807 685 K 685322
UBIO Proshares UltraPro Nasdaq Biotechnology 34.6 M 3.45696E+07 229 229 0.16% 0.00158686 180 K 179605

Wait, Before You Leave...